Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9X30
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $66,315
Award facts
- Contract value 100% obligated
- $66,315.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 14, 2026, the Defense Logistics Agency awarded a delivery order valued at $66,315.40 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price contract, which is non-set-aside and competitively awarded, is scheduled for ultimate completion by January 15, 2026, with performance taking place at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, which is valued at up to $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor and healthcare solutions provider that supplies essential medications, vaccines, medical devices, and specialized healthcare commodities to federal agencies. The parent company, Cencora, Inc., maintains its own significant Indefinite Delivery Contract with the DLA valued at up to $999,999,999.00 through December 31, 2031. Both entities have established themselves as critical vendors in the federal medical procurement landscape, leveraging their capabilities to meet government healthcare requirements through open competition without set-aside designations.
Quick answers
Who was awarded contract SPE2DR26F9X30?
SPE2DR26F9X30 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F9X30 worth?
The government has obligated $66,315 on SPE2DR26F9X30.
Is contract SPE2DR26F9X30 an order under another contract?
Yes. SPE2DR26F9X30 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9X30 competed?
The extent of competition for SPE2DR26F9X30 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award